X4 Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell XFOR and other ETFs, options, and stocks.

About XFOR

X4 Pharmaceuticals, Inc. is a late clinical-stage company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. Its clinical candidate is mavorixafor.

CEO

Paula S. Ragan

CEOPaula S. Ragan

Employees

143

Employees143

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

2010

Founded2010

Employees

143

Employees143

XFOR Key Statistics

Market cap

32.65M

Market cap32.65M

Price-Earnings ratio

-1.01

Price-Earnings ratio-1.01

Dividend yield

—

Dividend yield—

Average volume

1.63M

Average volume1.63M

High today

$0.1901

High today$0.1901

Low today

$0.1464

Low today$0.1464

Open price

$0.18

Open price$0.18

Volume

2.84M

Volume2.84M

52 Week high

$1.29

52 Week high$1.29

52 Week low

$0.1464

52 Week low$0.1464

X4 Pharmaceuticals

Why Robinhood?

X4 Pharmaceuticals, Inc. is a late clinical-stage company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. Its clinical candidate is mavorixafor. Show more

XFOR Key Statistics

X4 Pharmaceuticals, Inc. is a late clinical-stage company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. Its clinical candidate is mavorixafor.